Codexis, Inc. Equity-NMS: CDXS

$2.48 0.12 (December 3, 2023)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$2.36
Open :$2.4
Today's high :$2.49
Today's low :$2.2
52W low :$1.45
52W high :$6.98
1Y :-58.15%
5Y :-89.2%
Shares O/S :69.8 M
Market cap :173.1 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Codexis, Inc. today?

Codexis, Inc. (CDXS) share price as of December 3, 2023, is $2.48. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Codexis, Inc.?

Yes, Indian Investors can invest in the Codexis, Inc. (CDXS) Share by opening an international trading account with Angel One.

How can I purchase Codexis, Inc. shares in India?

Purchasing Codexis, Inc. (CDXS) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Codexis, Inc. (CDXS) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Codexis, Inc.?

Yes, you can purchase fractional shares of Codexis, Inc. (CDXS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Codexis, Inc.?

The market capitalization of Codexis, Inc. on December 3, 2023, is $173.1 M.

In which sector Codexis, Inc. belongs?

Codexis, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Codexis, Inc. stocks?

In order to invest in Codexis, Inc. (CDXS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Codexis, Inc.

Codexis, Inc. is an enzyme engineering company. The Company is engaged in discovering, developing and selling enzymes and other proteins. The Company commercializes its CodeEvolver enzyme engineering technology platform and products in the manufacture of small molecule pharmaceuticals. It operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Performance Enzymes segment consists primarily of two focus areas: biocatalysts for the sustainable manufacturing of pharmaceuticals, and enzymes for life science applications, including genomic sequencing and nucleic acid synthesis. The Novel Biotherapeutics segment offers product candidates include enzymes that are orally administered for function in the gastrointestinal tract (GI), such as its partnered product candidates CDX-7108 for the treatment of exocrine pancreatic insufficiency and CDX-6114 for the treatment of phenylketonuria, which are both in Phase I clinical trials.